Year 2011,
Volume: 1 Issue: 02, 75 - 77, 01.06.2011
Abstract
Fungal keratitis is an important ophthalmic problem in the developing world. Filamentous fungi are the most frequently reported pathogens in fungal keratitis. This report aimed to present a case with Lecythophora mutabilis keratitis that treatment failure was seen with topical and systemic amphotericin B lipid complex. Then she was treated successfully topical voriconazole.
Keywords
References
- Al-Badriyeh D, Neoh CF, Stewart K, Kong DC.. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 2010; 4: 391-405.
- Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: A review of current literature. Br J Ophthalmol 2008; 92:871– 878.
- Fintelmann RE, Gilmer W, Bloomer MM, Jeng BH. Recur- rent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty. Arch Ophthalmol. 2011;129:108-110.
- Marcus DM, Hull DS, Rubin RM, Newman CL. Lecythophora mutabilis endophthalmitis after long-term corneal cyanoacry- late. Retina. 1999;19:351-353.
- Scott IU, Cruz-Villegas V, Flynn HW Jr, Miller D. Delayed-on- set, bleb-associated endophthalmitis caused by Lecythopho- ra mutabilis. Am J Ophthalmol 2004;137:583-585.
- Riddell J, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 2011; 52:648-653.
- Goldblum D, Frueh BE, Zimmerli S, Böhnke M. Treatment of post-keratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea 2000; 19:853-857.
- Virata SR, Kylstra JA, Brown JC, Wohl DA, Cohen MS. Wors- ening of endogenous Candida albicans endophthalmitis dur- ing therapy with intravenous lipid complex amphotericin B. Clin Infect Dis 1999; 28:1177-1178.
- Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D. Suc- cessful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis. Ann Pharmacother 2009;43: 2103-2107.
- Dupuis A, Tournier N, Le Moal G, Venisse N. Preparation and stability of voriconazole eye drop solution. Antimicrob Agents Chemother. 2009; 53:798–799.
- Lau D, Ferdinands M, Leung L, et al. Penetration of voricon- azole 1% eyedrops into human aqueous humor. A prospec- tive open label study. Arch Ophthalmol 2008; 126: 343-346.
Year 2011,
Volume: 1 Issue: 02, 75 - 77, 01.06.2011
Abstract
Keywords
References
- Al-Badriyeh D, Neoh CF, Stewart K, Kong DC.. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 2010; 4: 391-405.
- Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: A review of current literature. Br J Ophthalmol 2008; 92:871– 878.
- Fintelmann RE, Gilmer W, Bloomer MM, Jeng BH. Recur- rent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty. Arch Ophthalmol. 2011;129:108-110.
- Marcus DM, Hull DS, Rubin RM, Newman CL. Lecythophora mutabilis endophthalmitis after long-term corneal cyanoacry- late. Retina. 1999;19:351-353.
- Scott IU, Cruz-Villegas V, Flynn HW Jr, Miller D. Delayed-on- set, bleb-associated endophthalmitis caused by Lecythopho- ra mutabilis. Am J Ophthalmol 2004;137:583-585.
- Riddell J, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 2011; 52:648-653.
- Goldblum D, Frueh BE, Zimmerli S, Böhnke M. Treatment of post-keratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea 2000; 19:853-857.
- Virata SR, Kylstra JA, Brown JC, Wohl DA, Cohen MS. Wors- ening of endogenous Candida albicans endophthalmitis dur- ing therapy with intravenous lipid complex amphotericin B. Clin Infect Dis 1999; 28:1177-1178.
- Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D. Suc- cessful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis. Ann Pharmacother 2009;43: 2103-2107.
- Dupuis A, Tournier N, Le Moal G, Venisse N. Preparation and stability of voriconazole eye drop solution. Antimicrob Agents Chemother. 2009; 53:798–799.
- Lau D, Ferdinands M, Leung L, et al. Penetration of voricon- azole 1% eyedrops into human aqueous humor. A prospec- tive open label study. Arch Ophthalmol 2008; 126: 343-346.
There are 11 citations in total.
Details
| Primary Language | English |
|---|---|
| Authors | |
| Publication Date | June 1, 2011 |
| DOI | https://doi.org/10.5799/ahinjs.02.2011.02.0018 |
| IZ | https://izlik.org/JA77GX23GH |
| Published in Issue | Year 2011 Volume: 1 Issue: 02 |